These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20373458)

  • 1. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b.
    Haagsma EB; Riezebos-Brilman A; van den Berg AP; Porte RJ; Niesters HG
    Liver Transpl; 2010 Apr; 16(4):474-7. PubMed ID: 20373458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient.
    Kamar N; Abravanel F; Garrouste C; Cardeau-Desangles I; Mansuy JM; Weclawiak H; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2010 Aug; 25(8):2792-5. PubMed ID: 20494897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
    Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
    Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E infection in liver transplant recipients.
    Unzueta A; Rakela J
    Liver Transpl; 2014 Jan; 20(1):15-24. PubMed ID: 24123928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis E virus infection in liver transplant recipients.
    Haagsma EB; Niesters HG; van den Berg AP; Riezebos-Brilman A; Porte RJ; Vennema H; Reimerink JH; Koopmans MP
    Liver Transpl; 2009 Oct; 15(10):1225-8. PubMed ID: 19790147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
    Nair S; Lipscomb J; Eason J
    Transplantation; 2008 Aug; 86(3):418-22. PubMed ID: 18698245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Esposito L; Cardeau-Desangles I; Mansuy JM; Selves J; Peron JM; Otal P; Muscari F; Izopet J
    Clin Infect Dis; 2010 Mar; 50(5):e30-3. PubMed ID: 20113176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E: when to treat and how to treat.
    Abbas Z; Afzal R
    Antivir Ther; 2014; 19(2):125-31. PubMed ID: 24192696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients.
    Yenice N; Mehtap O; Gümrah M; Arican N
    Turk J Gastroenterol; 2006 Jun; 17(2):94-8. PubMed ID: 16830289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current issues in the management of paediatric viral hepatitis.
    Yeung LT; Roberts EA
    Liver Int; 2010 Jan; 30(1):5-18. PubMed ID: 19840256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
    Neff GW; O'Brien CB; Cirocco R; Montalbano M; de Medina M; Ruiz P; Khaled AS; Bejarano PA; Safdar K; Hill MA; Tzakis AG; Schiff ER
    Liver Transpl; 2004 May; 10(5):595-8. PubMed ID: 15108250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series.
    Rodriguez-Luna H; Khatib A; Sharma P; De Petris G; Williams JW; Ortiz J; Hansen K; Mulligan D; Moss A; Douglas DD; Balan V; Rakela J; Vargas HE
    Transplantation; 2004 Jan; 77(2):190-4. PubMed ID: 14742979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis.
    Castedal M; Felldin M; Bäckman L; Olausson M; Friman S
    Transplant Proc; 2005 Oct; 37(8):3313-4. PubMed ID: 16298583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.
    Biselli M; Andreone P; Gramenzi A; Lorenzini S; Loggi E; Bonvicini F; Cursaro C; Bernardi M
    Dig Liver Dis; 2006 Jan; 38(1):27-32. PubMed ID: 16311084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis E virus infection in liver transplant recipients.
    Haagsma EB; van den Berg AP; Porte RJ; Benne CA; Vennema H; Reimerink JH; Koopmans MP
    Liver Transpl; 2008 Apr; 14(4):547-53. PubMed ID: 18383084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
    Kim SR; Imoto S; Mita K; Taniguchi M; Sasase N; Muramatsu A; Kudo M; Kitai S; El-Shamy A; Hotta H; Hayashi Y
    Digestion; 2009; 79(1):36-9. PubMed ID: 19246919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
    Baker RD; Dee D; Baker SS
    J Clin Gastroenterol; 2007 Jan; 41(1):111-4. PubMed ID: 17198073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Hepatitis C Eradication With Preservation of Renal Function in a Liver/kidney Transplant Recipient Using Pegylated Interferon and Ribavirin.
    Mukherjee S; Ariyarantha K
    Transplantation; 2007 Nov; 84(10):1374-5. PubMed ID: 18049127
    [No Abstract]   [Full Text] [Related]  

  • 20. Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.
    Iacob S; Gheorghe L; Hrehoret D; Becheanu G; Herlea V; Popescu I
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):165-72. PubMed ID: 18568137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.